Financial statements Modumpharma
Balance sheet data of MODUMPHARMA
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 4 809 194,36 | 5 572 628,48 | 12 639 929,46 | 26 090 244,74 | 31 632 168,39 | 40 984 189,72 |
A. Fixed assets | 88 339,86 | 83 191,26 | 75 211,98 | 18 124,06 | 19 000,32 | 303 742,02 |
B. Current assets | 4 720 854,50 | 5 489 437,22 | 12 564 717,48 | 26 072 120,68 | 31 613 168,07 | 40 680 447,70 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 4 809 194,36 | 5 572 628,48 | 12 639 929,46 | 26 090 244,74 | 31 632 168,39 | 40 984 189,72 |
A. Equity | 237 243,68 | 256 671,38 | 1 851 167,23 | 1 956 522,62 | 4 051 816,87 | 7 665 784,39 |
B. Liabilities and provisions for liabilities | 4 571 950,68 | 5 315 957,10 | 10 788 762,23 | 24 133 722,12 | 27 580 351,52 | 33 318 405,33 |
I. Long-term liabilities | - | 121 000,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | - | 5 194 957,10 | 10 788 762,23 | 24 133 722,12 | 27 580 351,52 | 33 318 405,33 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.